首页> Cancers> A Ten-Year Real-Life Experience with Pazopanib in Uterine Leyomiosarcoma in Two High-Specialized Centers in Italy: Effectiveness and Safety.

A Ten-Year Real-Life Experience with Pazopanib in Uterine Leyomiosarcoma in Two High-Specialized Centers in Italy: Effectiveness and Safety.

导出 OA

翻译打印收藏纠错

第一作者： Mara,Mantiero

第一单位： Department of Gynecologic Oncology, National Cancer Institute of Milan, Via Venezian 1, 20133 Milan, Italy.

作者： Mara,Mantiero ^[1] ; Marta,Bini ^[2] ; Maggie,Polignano ^[1] ; Luca,Porcu ^[3] ; Roberta,Sanfilippo ^[2] ; Chiara,Fabbroni ^[2] ; Gabriella,Parma ^[4] ; Mariateresa,Lapresa ^[4] ; Carmelo,Calidona ^[5] ; Cecilia,Silvestri ^[2] ; Andrea,Franza ^[2] ; Francesco,Raspagliesi ^[1] ; Nicoletta,Colombo ^[6] ; Monika,Ducceschi ^[1]

作者单位： Department of Gynecologic Oncology, National Cancer Institute of Milan, Via Venezian 1, 20133 Milan, Italy. ^[1] Department of Medical Oncology, National Cancer Institute of Milan, Via Venezian 1, 20133 Milan, Italy. ^[2] Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. ^[3] Gynecologic Oncology Division, European Institute of Oncology, Via Giuseppe Ripamonti, 435, 20141 Milan, Italy. ^[4] Gynecologic Oncology Division, European Institute of Oncology, Via Giuseppe Ripamonti, 435, 20141 Milan, Italy.;Department of Obstetrics and Gynecology, AOUI Verona, University of Verona, Piazzale Aristide Stefani 1, 37126 Verona, Italy. ^[5] Gynecologic Oncology Division, European Institute of Oncology, Via Giuseppe Ripamonti, 435, 20141 Milan, Italy.;University of Milan-Bicocca, Piazza dell'Ateneo Nuovo 1, 20126 Milan, Italy. ^[6]

关键词 effectiveness pazopanib safety survival uterine leyomiosarcoma

DOI 10.3390/cancers16010192

PMID 38201619

发布时间 2024-01-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交